The Journal of Experimental Medicine
BioLegend: New Th17, Treg Tools
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 26 July 2004 doi:10.1084/jem.20040446
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 200, Number 3, 399-404
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vivarelli, M. S.
Right arrow Articles by Geha, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vivarelli, M. S.
Right arrow Articles by Geha, R. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Definitive Report

RIP Links TLR4 to Akt and Is Essential for Cell Survival in Response to LPS Stimulation

Marina S. Vivarelli1, Douglas McDonald1, Mendy Miller1, Nicole Cusson2, Michelle Kelliher2, and Raif S. Geha1

1 Division of Immunology, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115
2 Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01655

Address correspondence to Raif S. Geha, Div. of Immunology, 1 Blackfan Circle, Boston, MA 02115. Tel: (617) 919-2482; Fax: (617) 730-0528; email: raif.geha{at}childrens.harvard.edu

Receptor-interacting protein (RIP) has been reported to associate with tumor necrosis–associated factor (TRAF)2 and TRAF6. Since TRAF2 and TRAF6 play important roles in CD40 signaling and TRAF6 plays an important role in TLR4 signaling, we examined the role of RIP in signaling via CD40 and TLR4. Splenocytes from RIP–/– mice proliferated and underwent isotype switching normally in response to anti-CD40–IL-4 but completely failed to do so in response to LPS–IL-4. However, they normally up-regulated TNF-{alpha} and IL-6 gene expression and CD54 and CD86 surface expression after LPS stimulation. RIP–/– splenocytes exhibited increased apoptosis and impaired Akt phosphorylation after LPS stimulation. These results suggest that RIP is essential for cell survival after TLR4 signaling and links TLR4 to the phosphatidylinositol 3 kinase–Akt pathway.

Key Words: NF{kappa}B • I{kappa}B • p38 MAP kinase • IL-6 • TNF-{alpha}



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS